Angiotensin-converting enzyme inhibitors predispose to hypotension refractory to norepinephrine but responsive to methylene blue

J Thorac Cardiovasc Surg. 2004 Feb;127(2):608. doi: 10.1016/j.jtcvs.2003.01.001.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Angiotensin-Converting Enzyme Inhibitors / adverse effects*
  • Cardiac Output, High / chemically induced
  • Cardiac Output, High / drug therapy
  • Dose-Response Relationship, Drug
  • Humans
  • Hypotension / chemically induced*
  • Hypotension / drug therapy*
  • Methylene Blue / administration & dosage
  • Methylene Blue / therapeutic use*
  • Norepinephrine / administration & dosage*
  • Vasoconstrictor Agents / administration & dosage*

Substances

  • Angiotensin-Converting Enzyme Inhibitors
  • Vasoconstrictor Agents
  • Methylene Blue
  • Norepinephrine